Can diabetes management programs create sustained improvements in disease outcomes?

Rothman, Russell L.; Elasy, Tom A.
December 2005
CMAJ: Canadian Medical Association Journal;12/6/2005, Vol. 173 Issue 12, p1467
Academic Journal
journal article
Comments on the study "Efficacy of Intensive Multitherapy for Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Trial," by J. Mérd et al., which was published in the December 6, 2005 issue of "Canadian Medical Association Journal." Discussion of the findings of the study; Opinion on the size of the sample used; Significance of the study for the intensive disease management.


Related Articles

  • Effects of chromium picolinate supplementation in type 2 diabetic patients. Rosinski Rocha, Niladê; Aparecida Carrara, Marcia; Stefanello, Talitha; Jordão Teixeira, Caio; Oliveira Pozzi, Ana Carla; Batista, Marcia Regina // Acta Scientiarum: Health Sciences;Jul-Dec2014, Vol. 36 Issue 2, p161 

    The effects of chromium picolinate in Type 2 diabetic patients are investigated. Seventeen Type 2 diabetic patients were randomly divided into two groups. The experimental group received fiber-rich hypocaloric diet and chromium picolinate whereas the control group received fiber-rich hypocaloric...

  • Overcoming Challenges and Improving Outcomes in the Management of Type 2 Diabetes. Peters, Ann // Journal of Managed Care Medicine;2012, Vol. 15 Issue 3, p52 

    The article discusses about the prevention of type 2 diabetes in U.S. as a communal effort. According to American Diabetes Association (ADA ), this can be achieved by early diagnosis, hence treatment, and achieving hemoglobin A1C values less than 7 percent. Patients with poor food control but...

  • Comparison of high fibre diets, basal insulin supplements, and flexible insulin treatment for non-insulin dependent (type II) diabetics poorly controlled with sulphonylureas. Scott, A.R.; Attenborough, Y.; Peacock, I.; Fletcher, E.; Jeffcoate, W.J.; Tattersall, R.B. // BMJ: British Medical Journal (International Edition);9/17/88, Vol. 297 Issue 6650, p707 

    Explores the efficacy of managements for non-insulin-dependent diabetes. Administration of high fiber diet, basal insulin supplements and a regimen of insulin for diabetics; Absence of changes in hemoglobin A[sub 1] concentration during high fiber diet; Improvement of control of diabetes by...

  • Combination Therapy for Type 2 Diabetes. Bell, David S. H. // American Family Physician;12/1/2001, Vol. 64 Issue 11, p1812 

    Editorial. Comments on the combination therapy for type 2 diabetes. Effectiveness of sulfonylurea as treatment for type 2 diabetes; Examination of the insulin therapy; Information on the combined insulin and oral therapy.

  • Future Therapeutic Directions: New Medications and Insulin Delivery in a Changing World for Effective Diabetes Management. Modi, Pankaj // Current Drug Discovery Technologies;Sep2009, Vol. 6 Issue 3, p200 

    Insulin remains a key to the management of diabetes. The early addition of insulin to oral therapy in type-2 patients is recognized as an effective option that can help improve glycemic control and reduces the complications and contribute to more favorable outcomes. Controlling blood glucose...

  • Meeting glycemic goals: Options beyond metformin. DeBenederte, Valerie // Drug Topics;Nov2012 Supplement, p8s 

    The article discusses the options in drug treatment for type 2 diabetes patients beyond the use of metformin in controlling glycemic and glycosylated hemoglobin (HbA1c) levels. Clinical professor Stefanie C. Nigro explains that approaches in diabetes management and patient care plan may differ...

  • Linagliptin plus metformin in patients with newly diagnosed type 2 diabetes and marked hyperglycemia. Ross, Stuart A.; Caballero, A. Enrique; Del Prato, Stefano; Gallwitz, Baptist; Lewis-D’Agostino, Diane; Bailes, Zelie; Thiemann, Sandra; Patel, Sanjay; Woerle, Hans-Juergen; von Eynatten, Maximilian; Lewis-D'Agostino, Diane // Postgraduate Medicine;Nov2016, Vol. 128 Issue 8, p747 

    Objectives: Few studies of oral glucose-lowering drugs exist in newly diagnosed type 2 diabetes (T2D) patients with marked hyperglycemia, and insulin is often proposed as initial treatment. We evaluated the oral initial combination of metformin and linagliptin, a dipeptidyl peptidase-4...

  • The Clinical Investigation of Securigera Securidaca (l.) Degen & Doerfler Seeds in Treatment of Type II Diabetic Patients: A Randomized, Double - Blind, Placebo - Controlled Study. Larijani, Bagher // Diabetes;Jun2007 Supplement 1, Vol. 56, pA562 

    Backgrounds and Aims: Securigera securidaca (L.) seeds is used by traditional herbalists for the treatment of diabetes in several parts of Iran. Clinical investigation of its efficacy and its toxicity in diabetic patients is of importance. Methods: A 2 - month randomized double blind clinical...

  • Barriers and Facilitators for Type-2 Diabetes Management in South Asians: A Systematic Review. Sohal, Tanveer; Sohal, Parmjit; King-Shier, Kathryn M.; Khan, Nadia A. // PLoS ONE;9/18/2015, Vol. 10 Issue 9, p1 

    Objective: Although South Asian populations have among the highest burden of type 2 diabetes in the world, their diabetes management remains poor. We systematically reviewed studies on South Asian patient’s perspectives on the barriers and facilitators to diabetes management. Methods: ...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics